Aurobindo Pharma falls 6% after USFDA classifies inspection as OAI Posted By: Unknown May 17, 2019 Leave a Reply Aurobindo Pharma has already submitted its initial response to USFDA from Latest News http://bit.ly/2Jr6W8o https://ift.tt/eA8V8J http://bit.ly/2SdCH5P Tweet Share Share Share Share
0 comments: